Iain Campbell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iain Campbell has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Harry Campbell
Usher Institute, University of Edinburgh, Edinburgh, UK
7 shared publications- Daniel J. Smith
Edinburgh Scotland The University of Edinburgh Division of Psychiatry
4 shared publications - Harry Campbell
Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, UK
3 shared publications Ivana Kamenska
Usher Institute, University of Edinburgh, UK
3 shared publicationsAilsa McLellan
Department of Paediatric Neurology, Royal Hospital for Children and Young People, NHS Lothian, Glasgow, UK
2 shared publications- Aja Louise Murray
University of Edinburgh
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Wiley in Health Expectations
- Vol. 29 (5) , e70887
Developing Best Practices in Co‐Production With Lived Experience Experts in Bipolar Research: Insights From the AMBIENT‐BD Lived Experience Advisory Panel
Introduction: Co‐production is becoming an established methodology in mental health research, yet there remains a lack of condition‐specific frameworks to guide its design and implementation. For bipolar disorder in particular, there is limited evidence on how to meaningfully engage lived experience experts in the context of possible mood instability and other impairments. This paper presents insights from a consultation with people with lived experience of bipolar disorder, aimed at developing recommendations for conducting co‐production with people with bipolar. Methods: A one‐off, 1‐h online consultation was conducted with four members of the AMBIENT‐BD Lived Experience Advisory Panel (LEAP). The consultation used a semi‐structured focus group format, guided by a topic guide, to explore strategies for recruiting and engaging co‐producers in bipolar disorder research. Data were analysed using reflexive thematic analysis. Results: Four overarching themes were developed: (i) Communicating with co‐producers‐ capturing how trusted channels and regular contact support recruitment and sustained engagement; (ii) Providing accessible information ‐ addressing the need to balance sufficient detail with readable, low‐burden formats during periods of instability; (iii) Building and sustaining trust ‐ highlighting trust in the research process and partnerships with third‐sector organisations as preconditions for meaningful involvement; and (iv) Perceived impact as a motivator ‐ reflecting how community belonging and tangible incentives shape willingness to participate. A provisional set of practical recommendations was derived from these themes, including recruiting through trusted organisations, using non‐technical language and multiple formats, offering meaningful incentives, and using low‐burden communication methods during periods of unwellness. Conclusion: Grounded in lived experience perspectives, this paper conceptualises co‐production as a relational process in which trust, accessible communication and visible impact form the foundation for meaningful engagement with people with bipolar disorder. Positioned as a consultative contribution on the IAP2 Spectrum of Public Participation, the paper offers practical, mental health‐specific guidance for researchers seeking to develop advisory groups and other participatory approaches with the bipolar population. Patient/Public Contribution: This study has been conducted in partnership with people with lived experience of bipolar disorder. They were involved in the conceptualisation, design and data collection of the study. They helped to inform the process of conducting a co‐production with people with bipolar disorder. Findings from the consultation were shared with them in a separate feedback session.
- 5 October 2026
- Published by Wiley in Health Expectations
- Vol. 29 (5) , e70887
Open AccessDeveloping Best Practices in Co‐Production With Lived Experience Experts in Bipolar Research: Insights From the AMBIENT‐BD Lived Experience Advisory Panel
Introduction: Co‐production is becoming an established methodology in mental health research, yet there remains a lack of condition‐specific frameworks to guide its design and implementation. For bipolar disorder in particular, there is limited evidence on how to meaningfully engage lived experience experts in the context of possible mood instability and other impairments. This paper presents insights from a consultation with people with lived experience of bipolar disorder, aimed at developing recommendations for conducting co‐production with people with bipolar. Methods: A one‐off, 1‐h online consultation was conducted with four members of the AMBIENT‐BD Lived Experience Advisory Panel (LEAP). The consultation used a semi‐structured focus group format, guided by a topic guide, to explore strategies for recruiting and engaging co‐producers in bipolar disorder research. Data were analysed using reflexive thematic analysis. Results: Four overarching themes were developed: (i) Communicating with co‐producers‐ capturing how trusted channels and regular contact support recruitment and sustained engagement; (ii) Providing accessible information ‐ addressing the need to balance sufficient detail with readable, low‐burden formats during periods of instability; (iii) Building and sustaining trust ‐ highlighting trust in the research process and partnerships with third‐sector organisations as preconditions for meaningful involvement; and (iv) Perceived impact as a motivator ‐ reflecting how community belonging and tangible incentives shape willingness to participate. A provisional set of practical recommendations was derived from these themes, including recruiting through trusted organisations, using non‐technical language and multiple formats, offering meaningful incentives, and using low‐burden communication methods during periods of unwellness. Conclusion: Grounded in lived experience perspectives, this paper conceptualises co‐production as a relational process in which trust, accessible communication and visible impact form the foundation for meaningful engagement with people with bipolar disorder. Positioned as a consultative contribution on the IAP2 Spectrum of Public Participation, the paper offers practical, mental health‐specific guidance for researchers seeking to develop advisory groups and other participatory approaches with the bipolar population. Patient/Public Contribution: This study has been conducted in partnership with people with lived experience of bipolar disorder. They were involved in the conceptualisation, design and data collection of the study. They helped to inform the process of conducting a co‐production with people with bipolar disorder. Findings from the consultation were shared with them in a separate feedback session.
- Open Access
- 22 September 2026
- Published by Springer Nature in Research Square
Developing best practices in co-production with lived experience experts in bipolar research: Insights from the AMBIENT-BD Lived Experience Advisory Panel
Introduction: Co-production is becoming an established methodology in mental health research, yet there remains a lack of condition-specific frameworks to guide its design and implementation. For bipolar disorder in particular, there is limited evidence on how to meaningfully engage lived experience experts in the context of possible mood instability and other impairments This paper presents insights from a consultation with people with lived experience of bipolar disorder, aimed at developing recommendations for conducting co-production with people with bipolar. Methods: A one-off, one-hour online consultation was conducted with four members of the AMBIENT-BD Lived Experience Advisory Panel (LEAP). The consultation used a semi-structured focus group format, guided by a topic guide, to explore strategies for recruiting and engaging co-producers in bipolar disorder research. Data were analysed using reflexive thematic analysis (1). Results: Four overarching themes were developed: (i) Communicating with co-producers- capturing how trusted channels and regular contact support recruitment and sustained engagement; (ii) Providing accessible information - addressing the need to balance sufficient detail with readable, low-burden formats during periods of instability; (iii) Building and sustaining trust - highlighting trust in the research process and partnerships with third-sector organisations as preconditions for meaningful involvement; and (iv) Perceived impact as a motivator - reflecting how community belonging and tangible incentives shape willingness to participate. A provisional set of practical recommendations was derived from these themes, including recruiting through trusted organisations, using non-technical language and multiple formats, offering meaningful incentives, and using low-burden communication methods during periods of unwellness. Conclusion- Grounded in lived experience perspectives, this paper conceptualises co-production as a relational process in which trust, accessible communication and visible impact form the foundation for meaningful engagement with people with bipolar disorder. Positioned as a consultative contribution on the IAP2 Spectrum of Public Participation, the paper offers practical, mental health specific guidance for researchers seeking to develop advisory groups and other participatory approaches with bipolar population.
- 22 September 2026
- Published by Springer Nature in Research Square
Open AccessDeveloping best practices in co-production with lived experience experts in bipolar research: Insights from the AMBIENT-BD Lived Experience Advisory Panel
Introduction: Co-production is becoming an established methodology in mental health research, yet there remains a lack of condition-specific frameworks to guide its design and implementation. For bipolar disorder in particular, there is limited evidence on how to meaningfully engage lived experience experts in the context of possible mood instability and other impairments This paper presents insights from a consultation with people with lived experience of bipolar disorder, aimed at developing recommendations for conducting co-production with people with bipolar. Methods: A one-off, one-hour online consultation was conducted with four members of the AMBIENT-BD Lived Experience Advisory Panel (LEAP). The consultation used a semi-structured focus group format, guided by a topic guide, to explore strategies for recruiting and engaging co-producers in bipolar disorder research. Data were analysed using reflexive thematic analysis (1). Results: Four overarching themes were developed: (i) Communicating with co-producers- capturing how trusted channels and regular contact support recruitment and sustained engagement; (ii) Providing accessible information - addressing the need to balance sufficient detail with readable, low-burden formats during periods of instability; (iii) Building and sustaining trust - highlighting trust in the research process and partnerships with third-sector organisations as preconditions for meaningful involvement; and (iv) Perceived impact as a motivator - reflecting how community belonging and tangible incentives shape willingness to participate. A provisional set of practical recommendations was derived from these themes, including recruiting through trusted organisations, using non-technical language and multiple formats, offering meaningful incentives, and using low-burden communication methods during periods of unwellness. Conclusion- Grounded in lived experience perspectives, this paper conceptualises co-production as a relational process in which trust, accessible communication and visible impact form the foundation for meaningful engagement with people with bipolar disorder. Positioned as a consultative contribution on the IAP2 Spectrum of Public Participation, the paper offers practical, mental health specific guidance for researchers seeking to develop advisory groups and other participatory approaches with bipolar population.
- Top Cited Papers
- 30 March 2026
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (4) , 508-520
Metabolic psychiatry targeting metabolic dysregulation in mental health
- 30 March 2026
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (4) , 508-520
Top Cited PapersMetabolic psychiatry targeting metabolic dysregulation in mental health
- Open Access
- 19 July 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (11) , 5600-5612
Metabolic plasticity: an evolutionary perspective on metabolic and circadian dysregulation in bipolar disorder
The emerging field of metabolic psychiatry has brought mechanisms of metabolic dysfunction into focus in bipolar disorder research. In this manuscript, we propose that the metabolic features of bipolar disorder provide a new vector from which to understand the role of circadian dysfunction in this condition. A notable feature of bipolar disorder is the photoperiod driven, seasonal occurrence of symptoms and episodes mediated by circadian systems, with mania occurring more frequently in the spring and autumn at times of rapid rate of change in photoperiod, and depression being more prevalent in the winter when photoperiod is attenuated. In this manuscript we note that seasonal adaptations in metabolism are highly conserved evolutionary traits across diverse taxa. Several of the underlying mechanisms mediating seasonal changes in metabolism are conserved in human biology and are implicated in bipolar disorder pathophysiology. Such mechanisms encompass targets of lithium involved in insulin signaling (the phosphatidylinositol cycle, GSK3β and Akt), clock genes (CLOCK and BMAL1), targets of psychiatric and metabolic medications (mTOR and AMPK) and hormonal signaling (melatonin and cortisol). We propose that bipolar disorder may represent a dysregulation of conserved mechanisms of chronometabolic regulation and provide a discussion of the evolutionary context of such mechanisms. Genetic predisposition coupled to novel environmental inputs to human biology including artificial light at night and sustained refined sugar and carbohydrate intake may contribute to states of metabolic and circadian dysregulation in bipolar disorder underlying episodes of mania and depression.
- 19 July 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (11) , 5600-5612
Open AccessMetabolic plasticity: an evolutionary perspective on metabolic and circadian dysregulation in bipolar disorder
The emerging field of metabolic psychiatry has brought mechanisms of metabolic dysfunction into focus in bipolar disorder research. In this manuscript, we propose that the metabolic features of bipolar disorder provide a new vector from which to understand the role of circadian dysfunction in this condition. A notable feature of bipolar disorder is the photoperiod driven, seasonal occurrence of symptoms and episodes mediated by circadian systems, with mania occurring more frequently in the spring and autumn at times of rapid rate of change in photoperiod, and depression being more prevalent in the winter when photoperiod is attenuated. In this manuscript we note that seasonal adaptations in metabolism are highly conserved evolutionary traits across diverse taxa. Several of the underlying mechanisms mediating seasonal changes in metabolism are conserved in human biology and are implicated in bipolar disorder pathophysiology. Such mechanisms encompass targets of lithium involved in insulin signaling (the phosphatidylinositol cycle, GSK3β and Akt), clock genes (CLOCK and BMAL1), targets of psychiatric and metabolic medications (mTOR and AMPK) and hormonal signaling (melatonin and cortisol). We propose that bipolar disorder may represent a dysregulation of conserved mechanisms of chronometabolic regulation and provide a discussion of the evolutionary context of such mechanisms. Genetic predisposition coupled to novel environmental inputs to human biology including artificial light at night and sustained refined sugar and carbohydrate intake may contribute to states of metabolic and circadian dysregulation in bipolar disorder underlying episodes of mania and depression.
- Open Access
- 17 April 2025
- Published by Center for Open Science in PsyArXiv
Metabolic Plasticity. An Evolutionary Perspective on Bipolar Disorder, Insulin Signalling and Ketosis
The emerging field of Metabolic Psychiatry has brought mechanisms of metabolic dysfunction into focus in bipolar disorder research. In this manuscript we highlight the preserved evolutionary roots of mechanisms of metabolic adaptation and their interaction with established mechanisms of circadian dysfunction in bipolar disorder. Throughout evolutionary history, selective pressures in the environment caused many biological organisms to develop patterns of seasonal metabolic adaptation. States of hypometabolism, characterised by reduced basal metabolic rate, suppression of insulin signalling and glucose metabolism, suppressed circadian rhythmicity, and increased reliance on fatty acid and ketone body metabolism were adaptive during states such as torpor and hibernation. Conversely, seasonal hypermetabolic states were advantageous for survival in scenarios such as migration, where increased fatty acid metabolism was also a critical component of physiological adaptations. The mechanisms underpinning these metabolic changes are intricately interlinked with circadian systems, which are responsive to changes in photoperiod and drive patterns of seasonal adaptation. While humans have been largely removed from the selective pressures of our evolutionary predecessors, similar chrono-metabolic mechanisms underlying seasonal adaptation are preserved in human biology, and play important roles in tuning metabolism to environmental cues. In this manuscript we highlight evolutionarily preserved metabolic and circadian mechanisms which are implicated in bipolar disorder pathophysiology, and we compare these to mechanisms which have mediated seasonal metabolic adaptation throughout evolutionary history.
- 17 April 2025
- Published by Center for Open Science in PsyArXiv
Open AccessMetabolic Plasticity. An Evolutionary Perspective on Bipolar Disorder, Insulin Signalling and Ketosis
The emerging field of Metabolic Psychiatry has brought mechanisms of metabolic dysfunction into focus in bipolar disorder research. In this manuscript we highlight the preserved evolutionary roots of mechanisms of metabolic adaptation and their interaction with established mechanisms of circadian dysfunction in bipolar disorder. Throughout evolutionary history, selective pressures in the environment caused many biological organisms to develop patterns of seasonal metabolic adaptation. States of hypometabolism, characterised by reduced basal metabolic rate, suppression of insulin signalling and glucose metabolism, suppressed circadian rhythmicity, and increased reliance on fatty acid and ketone body metabolism were adaptive during states such as torpor and hibernation. Conversely, seasonal hypermetabolic states were advantageous for survival in scenarios such as migration, where increased fatty acid metabolism was also a critical component of physiological adaptations. The mechanisms underpinning these metabolic changes are intricately interlinked with circadian systems, which are responsive to changes in photoperiod and drive patterns of seasonal adaptation. While humans have been largely removed from the selective pressures of our evolutionary predecessors, similar chrono-metabolic mechanisms underlying seasonal adaptation are preserved in human biology, and play important roles in tuning metabolism to environmental cues. In this manuscript we highlight evolutionarily preserved metabolic and circadian mechanisms which are implicated in bipolar disorder pathophysiology, and we compare these to mechanisms which have mediated seasonal metabolic adaptation throughout evolutionary history.
- Top Cited PapersOpen Access
- 25 February 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (2) , e34
A pilot study of a ketogenic diet in bipolar disorder: clinical, metabolic and magnetic resonance spectroscopy findings
Background: Preliminary evidence suggests that a ketogenic diet may be effective for bipolar disorder. Aims: To assess the impact of a ketogenic diet in bipolar disorder on clinical, metabolic and magnetic resonance spectroscopy outcomes. Method: Euthymic individuals with bipolar disorder (N = 27) were recruited to a 6- to 8-week single-arm open pilot study of a modified ketogenic diet. Clinical, metabolic and MRS measures were assessed before and after the intervention. Results: Of 27 recruited participants, 26 began and 20 completed the ketogenic diet. For participants completing the intervention, mean body weight fell by 4.2 kg (P < 0.001), mean body mass index fell by 1.5 kg/m2 (P < 0.001) and mean systolic blood pressure fell by 7.4 mmHg (P < 0.041). The euthymic participants had average baseline and follow-up assessments consistent with them being in the euthymic range with no statistically significant changes in Affective Lability Scale-18, Beck Depression Inventory and Young Mania Rating Scale. In participants providing reliable daily ecological momentary assessment data (n = 14), there was a positive correlation between daily ketone levels and self-rated mood (r = 0.21, P < 0.001) and energy (r = 0.19 P < 0.001), and an inverse correlation between ketone levels and both impulsivity (r = −0.30, P < 0.001) and anxiety (r = −0.19, P < 0.001). From the MRS measurements, brain glutamate plus glutamine concentration decreased by 11.6% in the anterior cingulate cortex (P = 0.025) and fell by 13.6% in the posterior cingulate cortex (P = <0.001). Conclusions: These findings suggest that a ketogenic diet may be clinically useful in bipolar disorder, for both mental health and metabolic outcomes. Replication and randomised controlled trials are now warranted.
- 25 February 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (2) , e34
Top Cited PapersOpen AccessA pilot study of a ketogenic diet in bipolar disorder: clinical, metabolic and magnetic resonance spectroscopy findings
Background: Preliminary evidence suggests that a ketogenic diet may be effective for bipolar disorder. Aims: To assess the impact of a ketogenic diet in bipolar disorder on clinical, metabolic and magnetic resonance spectroscopy outcomes. Method: Euthymic individuals with bipolar disorder (N = 27) were recruited to a 6- to 8-week single-arm open pilot study of a modified ketogenic diet. Clinical, metabolic and MRS measures were assessed before and after the intervention. Results: Of 27 recruited participants, 26 began and 20 completed the ketogenic diet. For participants completing the intervention, mean body weight fell by 4.2 kg (P < 0.001), mean body mass index fell by 1.5 kg/m2 (P < 0.001) and mean systolic blood pressure fell by 7.4 mmHg (P < 0.041). The euthymic participants had average baseline and follow-up assessments consistent with them being in the euthymic range with no statistically significant changes in Affective Lability Scale-18, Beck Depression Inventory and Young Mania Rating Scale. In participants providing reliable daily ecological momentary assessment data (n = 14), there was a positive correlation between daily ketone levels and self-rated mood (r = 0.21, P < 0.001) and energy (r = 0.19 P < 0.001), and an inverse correlation between ketone levels and both impulsivity (r = −0.30, P < 0.001) and anxiety (r = −0.19, P < 0.001). From the MRS measurements, brain glutamate plus glutamine concentration decreased by 11.6% in the anterior cingulate cortex (P = 0.025) and fell by 13.6% in the posterior cingulate cortex (P = <0.001). Conclusions: These findings suggest that a ketogenic diet may be clinically useful in bipolar disorder, for both mental health and metabolic outcomes. Replication and randomised controlled trials are now warranted.
- Open Access
- 17 December 2024
- Published by Center for Open Science in PsyArXiv
Bipolar Disorder and Ketogenic Diet A Survey of The Lived Experience of Over 100 Patients
Background:A ketogenic diet, an established treatment for refractory epilepsy, is now being investigated as a potential treatment for bipolar disorder, a condition in which anti-seizure medications are commonly utilized in treatment. This study aims to better understand the lived experience of bipolar disorder patients adhering to a ketogenic diet to identify potential benefits and risks.Methods:A structured online questionnaire was distributed to individuals diagnosed with bipolar disorder who have adhered to a ketogenic diet. The questionnaire collected data on demographics, diet adherence, symptoms and episodes, cognitive function, physical health, and quality of life. Quantitative and qualitative methods were used to analyze the data.Results:A total of 103 participants completed the questionnaire. 67.8% of participants maintained an average ketone level of 1-3 mmol/L. 20.3% maintained an average level above 3 mmol/L and 11.9% maintained an average level below 1 mmol/L. 47% followed a classic ketogenic diet and 28% followed a modified ketogenic diet.The mean number of reported episodes of mania per year decreased by 81% (3.08 to 0.58) when adhering to a ketogenic diet. And the mean number of reported episodes of depression per year decreased 79% (8.24 to 1.7) when adhering to a ketogenic diet.Respondents reported that symptoms of depression (moderate to very severe) decreased by 66.9 percentage points (from 85.5% to 18.6%) after beginning a ketogenic diet. Those reporting no symptoms of depression increased by 40 percentage points (from 5.8% to 46.1%). Hypomania (moderate to very severe) decreased by 42.1 percentage points (from 55.7% to 13.6%). Those reporting no hypomania increased by 35.3 percentage points (from 15.2% to 50.5%). Mania (moderate to very severe): decreased by 20.3 percentage points (from 30.3% to 10%). Those reporting no symptoms of mania increased by 34.7 percentage points (from 47.5% to 82.2%). Thematic analysis of the qualitative data revealed that many participants reported improvements in their quality of life, cognitive function and memory, physical health (including weight loss, and reductions in blood pressure) and social and occupational functioning. Some respondents reported side effects in the transition period into ketosis such as gastro-intestinal issues and fatigue, these were mostly mild and improved when established in ketosis, but were severe in a minority of respondents.Conclusions:Individuals living with bipolar disorder and adhering to a ketogenic diet report substantial benefits to their mental and physical health. These include reductions in occurrence and severity of episodes of depression, mania and hypomania, improved cognitive function, improved energy and weight loss. Most respondents adhered to forms of the diet and ketone ranges consistent with existing epilepsy guidelines. Side effects were reported in the adaptation period to ketosis, but these improved in most cases when in established ketosis. These findings from the lived experience of bipolar patients suggest that a ketogenic diet should be further investigated as a potential treatment for bipolar disorder. Randomized controlled trials are needed to study these effects and explore which patients may benefit from this intervention.
- 17 December 2024
- Published by Center for Open Science in PsyArXiv
Open AccessBipolar Disorder and Ketogenic Diet A Survey of The Lived Experience of Over 100 Patients
Background:A ketogenic diet, an established treatment for refractory epilepsy, is now being investigated as a potential treatment for bipolar disorder, a condition in which anti-seizure medications are commonly utilized in treatment. This study aims to better understand the lived experience of bipolar disorder patients adhering to a ketogenic diet to identify potential benefits and risks.Methods:A structured online questionnaire was distributed to individuals diagnosed with bipolar disorder who have adhered to a ketogenic diet. The questionnaire collected data on demographics, diet adherence, symptoms and episodes, cognitive function, physical health, and quality of life. Quantitative and qualitative methods were used to analyze the data.Results:A total of 103 participants completed the questionnaire. 67.8% of participants maintained an average ketone level of 1-3 mmol/L. 20.3% maintained an average level above 3 mmol/L and 11.9% maintained an average level below 1 mmol/L. 47% followed a classic ketogenic diet and 28% followed a modified ketogenic diet.The mean number of reported episodes of mania per year decreased by 81% (3.08 to 0.58) when adhering to a ketogenic diet. And the mean number of reported episodes of depression per year decreased 79% (8.24 to 1.7) when adhering to a ketogenic diet.Respondents reported that symptoms of depression (moderate to very severe) decreased by 66.9 percentage points (from 85.5% to 18.6%) after beginning a ketogenic diet. Those reporting no symptoms of depression increased by 40 percentage points (from 5.8% to 46.1%). Hypomania (moderate to very severe) decreased by 42.1 percentage points (from 55.7% to 13.6%). Those reporting no hypomania increased by 35.3 percentage points (from 15.2% to 50.5%). Mania (moderate to very severe): decreased by 20.3 percentage points (from 30.3% to 10%). Those reporting no symptoms of mania increased by 34.7 percentage points (from 47.5% to 82.2%). Thematic analysis of the qualitative data revealed that many participants reported improvements in their quality of life, cognitive function and memory, physical health (including weight loss, and reductions in blood pressure) and social and occupational functioning. Some respondents reported side effects in the transition period into ketosis such as gastro-intestinal issues and fatigue, these were mostly mild and improved when established in ketosis, but were severe in a minority of respondents.Conclusions:Individuals living with bipolar disorder and adhering to a ketogenic diet report substantial benefits to their mental and physical health. These include reductions in occurrence and severity of episodes of depression, mania and hypomania, improved cognitive function, improved energy and weight loss. Most respondents adhered to forms of the diet and ketone ranges consistent with existing epilepsy guidelines. Side effects were reported in the adaptation period to ketosis, but these improved in most cases when in established ketosis. These findings from the lived experience of bipolar patients suggest that a ketogenic diet should be further investigated as a potential treatment for bipolar disorder. Randomized controlled trials are needed to study these effects and explore which patients may benefit from this intervention.
- Top Cited PapersOpen Access
- 25 January 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (5) , 1521-1527
The metabolic overdrive hypothesis: hyperglycolysis and glutaminolysis in bipolar mania
Evidence from diverse areas of research including chronobiology, metabolomics and magnetic resonance spectroscopy indicate that energy dysregulation is a central feature of bipolar disorder pathophysiology. In this paper, we propose that mania represents a condition of heightened cerebral energy metabolism facilitated by hyperglycolysis and glutaminolysis. When oxidative glucose metabolism becomes impaired in the brain, neurons can utilize glutamate as an alternative substrate to generate energy through oxidative phosphorylation. Glycolysis in astrocytes fuels the formation of denovo glutamate, which can be used as a mitochondrial fuel source in neurons via transamination to alpha-ketoglutarate and subsequent reductive carboxylation to replenish tricarboxylic acid cycle intermediates. Upregulation of glycolysis and glutaminolysis in this manner causes the brain to enter a state of heightened metabolism and excitatory activity which we propose to underlie the subjective experience of mania. Under normal conditions, this mechanism serves an adaptive function to transiently upregulate brain metabolism in response to acute energy demand. However, when recruited in the long term to counteract impaired oxidative metabolism it may become a pathological process. In this article, we develop these ideas in detail, present supporting evidence and propose this as a novel avenue of investigation to understand the biological basis for mania.
- 25 January 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (5) , 1521-1527
Top Cited PapersOpen AccessThe metabolic overdrive hypothesis: hyperglycolysis and glutaminolysis in bipolar mania
Evidence from diverse areas of research including chronobiology, metabolomics and magnetic resonance spectroscopy indicate that energy dysregulation is a central feature of bipolar disorder pathophysiology. In this paper, we propose that mania represents a condition of heightened cerebral energy metabolism facilitated by hyperglycolysis and glutaminolysis. When oxidative glucose metabolism becomes impaired in the brain, neurons can utilize glutamate as an alternative substrate to generate energy through oxidative phosphorylation. Glycolysis in astrocytes fuels the formation of denovo glutamate, which can be used as a mitochondrial fuel source in neurons via transamination to alpha-ketoglutarate and subsequent reductive carboxylation to replenish tricarboxylic acid cycle intermediates. Upregulation of glycolysis and glutaminolysis in this manner causes the brain to enter a state of heightened metabolism and excitatory activity which we propose to underlie the subjective experience of mania. Under normal conditions, this mechanism serves an adaptive function to transiently upregulate brain metabolism in response to acute energy demand. However, when recruited in the long term to counteract impaired oxidative metabolism it may become a pathological process. In this article, we develop these ideas in detail, present supporting evidence and propose this as a novel avenue of investigation to understand the biological basis for mania.
- Open Access
A Pilot Study of a Ketogenic Diet in Bipolar Disorder: Clinical, Metabolic and Magnetic Resonance Spectroscopy Findings
Background: Preliminary evidence suggests that a ketogenic diet may be effective for bipolar disorder. Aims: To assess the impact of a ketogenic diet in bipolar disorder on clinical, metabolic and brain magnetic resonance spectroscopy (MRS) outcomes. Method: Euthymic individuals with bipolar disorder (N=27) were recruited to a 6-8 week single-arm open pilot study of a modified ketogenic diet. Clinical, metabolic and MRS measures were assessed before and after the intervention. Results: Of 27 recruited participants, 26 began and 20 completed the ketogenic diet for 6-8 weeks. For participants completing the intervention, mean body weight fell by 4.2kg (p2 (p<0.001) and mean systolic blood pressure fell by 7.4 mmHg (p<0.041). All participants had baseline and follow up assessments consistent with them being in the euthymic range with no statistically significant changes in symptoms (assessed by the Affective Lability Scale-18, Beck’s Depression Inventory and Young Mania Rating Scale). In some participants (those providing reliable daily ecological momentary assessment data; n=14) there was a positive correlation between daily ketone levels and self-rated mood (r=0.21, p<0.001) and energy (r=0.19 p<0.001), and an inverse correlation between ketone levels and both impulsivity (r =-.30, p<0.001) and anxiety (r=-0.19, p<0.001). From the MRS measurements, brain Glx (glutamate plus glutamine concentration) decreased by 11.6% in the anterior cingulate cortex ACC (p=0.025) and fell by 13.6% in the posterior cingulate cortex (PCC) (p=<0.001). Conclusions: These preliminary findings suggest that a ketogenic diet may be clinically useful in bipolar disorder, for both mental health and metabolic outcomes. Replication and randomised controlled trials are now warranted. Study Registration Number: ISRCTN61613198
Open AccessA Pilot Study of a Ketogenic Diet in Bipolar Disorder: Clinical, Metabolic and Magnetic Resonance Spectroscopy Findings
Background: Preliminary evidence suggests that a ketogenic diet may be effective for bipolar disorder. Aims: To assess the impact of a ketogenic diet in bipolar disorder on clinical, metabolic and brain magnetic resonance spectroscopy (MRS) outcomes. Method: Euthymic individuals with bipolar disorder (N=27) were recruited to a 6-8 week single-arm open pilot study of a modified ketogenic diet. Clinical, metabolic and MRS measures were assessed before and after the intervention. Results: Of 27 recruited participants, 26 began and 20 completed the ketogenic diet for 6-8 weeks. For participants completing the intervention, mean body weight fell by 4.2kg (p2 (p<0.001) and mean systolic blood pressure fell by 7.4 mmHg (p<0.041). All participants had baseline and follow up assessments consistent with them being in the euthymic range with no statistically significant changes in symptoms (assessed by the Affective Lability Scale-18, Beck’s Depression Inventory and Young Mania Rating Scale). In some participants (those providing reliable daily ecological momentary assessment data; n=14) there was a positive correlation between daily ketone levels and self-rated mood (r=0.21, p<0.001) and energy (r=0.19 p<0.001), and an inverse correlation between ketone levels and both impulsivity (r =-.30, p<0.001) and anxiety (r=-0.19, p<0.001). From the MRS measurements, brain Glx (glutamate plus glutamine concentration) decreased by 11.6% in the anterior cingulate cortex ACC (p=0.025) and fell by 13.6% in the posterior cingulate cortex (PCC) (p=<0.001). Conclusions: These preliminary findings suggest that a ketogenic diet may be clinically useful in bipolar disorder, for both mental health and metabolic outcomes. Replication and randomised controlled trials are now warranted. Study Registration Number: ISRCTN61613198
- Open Access
- 29 August 2022
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-8
Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder
In this paper, we propose that lithium may exert its therapeutic effect in bipolar disorder by acting on insulin signaling pathways. Specifically, we assess the importance of the phosphatidylinositol 3-kinase/Protein Kinase B (PI3K/Akt) insulin signaling pathway and we assess how the action of lithium on both glycogen synthase kinase-3 (GSK3) and the phosphatidylinositol cycle may lead to mood stabilization mediated by PI3K/Akt insulin signaling. We also highlight evidence that several other actions of lithium (including effects on Akt, Protein kinase C (PKC), and sodium myo-inositol transporters) are putative mediators of insulin signaling. This novel mode of action of lithium is consistent with an emerging consensus that energy dysregulation represents a core deficit in bipolar disorder. It may also provide context for the significant co-morbidity between bipolar disorder, type 2 diabetes, and other forms of metabolic illness characterized by impaired glucose metabolism. It is suggested that developments in assessing neuronal insulin signaling using extracellular vesicles would allow for this hypothesis to be tested in bipolar disorder patients.
- 29 August 2022
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-8
Open AccessInsulin signaling as a therapeutic mechanism of lithium in bipolar disorder
In this paper, we propose that lithium may exert its therapeutic effect in bipolar disorder by acting on insulin signaling pathways. Specifically, we assess the importance of the phosphatidylinositol 3-kinase/Protein Kinase B (PI3K/Akt) insulin signaling pathway and we assess how the action of lithium on both glycogen synthase kinase-3 (GSK3) and the phosphatidylinositol cycle may lead to mood stabilization mediated by PI3K/Akt insulin signaling. We also highlight evidence that several other actions of lithium (including effects on Akt, Protein kinase C (PKC), and sodium myo-inositol transporters) are putative mediators of insulin signaling. This novel mode of action of lithium is consistent with an emerging consensus that energy dysregulation represents a core deficit in bipolar disorder. It may also provide context for the significant co-morbidity between bipolar disorder, type 2 diabetes, and other forms of metabolic illness characterized by impaired glucose metabolism. It is suggested that developments in assessing neuronal insulin signaling using extracellular vesicles would allow for this hypothesis to be tested in bipolar disorder patients.